Myriad Genetics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $210,600 | $213,300 | $211,500 | $202,200 |
Gross Profit | 150,900 | 149,800 | 147,100 | 137,600 |
EBITDA | -2,200 | -21,200 | -9,700 | |
EBIT | -17,800 | -36,300 | -25,400 | |
Net Income | -42,500 | -22,100 | -36,700 | -26,000 |
Net Change In Cash | 210,600 | 213,300 | 211,500 | 202,200 |
Free Cash Flow | 700 | -5,600 | -6,300 | -27,200 |
Cash | 102,400 | 99,900 | 92,400 | 96,900 |
Basic Shares | 91,300 | 90,900 | 90,600 | 89,900 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $837,600 | $753,200 | $678,400 | $690,600 |
Gross Profit | 585,400 | 517,000 | 476,400 | 493,000 |
EBITDA | -186,100 | -67,800 | 14,100 | |
EBIT | -248,000 | -123,700 | -48,700 | |
Net Income | -127,300 | -263,300 | -112,000 | -27,200 |
Net Change In Cash | 837,600 | 753,200 | 678,400 | 690,600 |
Free Cash Flow | -38,400 | -184,200 | -151,600 | 200 |
Cash | 102,400 | 132,100 | 56,900 | 258,400 |
Basic Shares | 91,300 | 82,800 | 80,600 | 78,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.03 |
2024-09-30 | $0.06 |
2024-06-30 | $0.05 |
2024-03-31 | -$0.01 |
